胆汁酸-胺脱酸结合物作为脂质纳米粒子配方中的有希望的添加剂,用于siRNA传递

相关实验视频

Updated: Jan 17, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Jun Hyuk Lee¹, Hyeondo Lee¹, Yeonho Bae¹

¹Department of Bioscience and Biotechnology, Konkuk University, Seoul 143-701, Republic of Korea.

Bioconjugate chemistry

|September 16, 2025

概括

研究人员开发了一种新的胆汁酸-histidine decapeptide结合物,用于减少脂质纳米颗粒 (LNP) 中的可离子化脂质. 这项创新通过改善肝脏积累和减少炎症来提高siRNA的治疗安全性和有效性.

科学领域:

生物技术是生物技术.
药物输送系统药物输送系统
纳米医学是一种纳米医学.

背景情况:

重复服用siRNA治疗药物可能会导致体内安全问题,原因是电离性脂质的积累.
脂质纳米颗粒 (LNP) 对于siRNA传递至关重要,但通常需要高比例的可离子化脂质.

研究的目的:

为了研究胆汁酸-histidine decapeptide (H10) 结合物作为一种生物相容的添加剂,以减少LNP中的可离子化脂质.
通过使用新型结合物来评估用减少电离性脂质配制的LNP的疗效和安全性.

主要方法:

合成一种石灰酸 (LCA) -H10结合物 (LH结合物).
低电离性脂质LNP (LiLNP) 的配方,其中包括LH联物 (LiLNP-LH).
评估基因沉默活性,粒子特征,体内肝脏积累和炎症性细胞因子释放.

主要成果:

与LiLNP相比,含有LH合物的LiLNP (LiLNP-LH) 显示出增强的基因沉默.
与传统的高电离性脂质LNP (HiLNP) 相比,LiLNP-LH显示肝脏积累增加,炎症性细胞因子释放显著减少.
粒子大小和形态在LiLNP和LiLNP-LH之间仍然相似.

结论:

液联体有效地降低了LNP所需的电离性脂质的比例.
这一战略为开发更安全,更有效的siRNA疗法提供了一个有前途的方法.
开发的LiLNP-LH系统展示了作为多样化的siRNA应用的多功能载体的潜力.

更多相关视频

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...